Endpoints News Dec 16, 2025 Nektar's immunology drug misses in Phase 2b, execs cite enrollment errors
BioPharma Dive Dec 16, 2025 Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study
Endpoints News Dec 16, 2025 J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell
Endpoints News Dec 16, 2025 OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ